Needham Reiterates Buy on Generation Bio, Maintains $14 Price Target

Benzinga · 05/11/2023 09:56
Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:GBIO) with a Buy and maintains $14 price target.